Why are clinicians not embracing the results from pivotal clinical trials in severe sepsis? A bayesian analysis.
<h4>Background</h4>Five pivotal clinical trials (Intensive Insulin Therapy; Recombinant Human Activated Protein C [rhAPC]; Low-Tidal Volume; Low-Dose Steroid; Early Goal-Directed Therapy [EGDT]) demonstrated mortality reduction in patients with severe sepsis and expert guidelines have re...
Guardado en:
Autores principales: | Andre C Kalil, Junfeng Sun |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b2d19aafa17f44e1a4056f95494bca50 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinician Delivery of Virtual Pivotal Response Treatment with Children with Autism during the COVID-19 Pandemic
por: Devon M. White, et al.
Publicado: (2021) -
The design of a Bayesian adaptive clinical trial of tranexamic acid in severely injured children
por: John M. VanBuren, et al.
Publicado: (2021) -
Dignity of Older Persons With Mental Health Conditions: Why Should Clinicians Care?
por: Debanjan Banerjee, et al.
Publicado: (2021) -
How to read a published clinical trial: a practical guide for clinicians
por: Mohamad B Sonbol, et al.
Publicado: (2020) -
Embracing the Complexity of Neurodevelopmental Disorders
por: Michele Roccella, et al.
Publicado: (2021)